Prijeđi na sadržaj

Loksapin

Izvor: Wikipedija
Loksapin
(IUPAC) ime
2-hloro-11-(4-metilpiperazin-1-il)dibenzo[b,f][1,4]oksazepin
Klinički podaci
AHFS/Drugs.com Monografija
MedlinePlus a682311
Identifikatori
CAS broj 1977-10-2
ATC kod N05AH01
PubChem[1][2] 3964
DrugBank DB00408
ChemSpider[3] 3827
UNII LER583670J DaY
KEGG[4] D02340 DaY
ChEBI CHEBI:50841 DaY
ChEMBL[5] CHEMBL831 DaY
Hemijski podaci
Formula C18H18ClN3O 
Mol. masa 327,808 g/mol
SMILES eMolekuli & PubHem
Fizički podaci
Tačka topljenja 109–110 °C (228–230 °F)
Farmakokinetički podaci
Metabolizam Gastrointestinalni, pik koncentracije se javlja između 1-2 sata
Poluvreme eliminacije Oralno 4 h
Izlučivanje Najveći deo se izlučuje u toku 24 sata
Farmakoinformacioni podaci
Trudnoća ?
Pravni status

Loksapin (Loksapak, Loksitan) je tipični antipsihotik koji se prvenstveno koristi za lečenje šizofrenije. On je član (benzodiazepinske) dibenzoksazepinske klase, te je strukturno srodan sa klozapinom.[6]

Loksapin može da bude metabolisan N-demetilacijom do amoksapina, tetracikličnog antidepresiva.[7]

Hemija

[uredi | uredi kod]

Jedan od mogućih sintetičkih pristupa je:[8]

Reference

[uredi | uredi kod]
  1. Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519.  edit
  2. Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1. 
  3. Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846.  edit
  4. Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast 17 (1): 48–55. DOI:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H. 
  5. Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594.  edit
  6. Glazer WM (1999). „Does loxapine have "atypical" properties? Clinical evidence”. The Journal of Clinical Psychiatry 60 (Suppl 10): 42–6. PMID 10340686. 
  7. Cheung SW, Tang SW, Remington G (March 1991). „Simultaneous quantitation of loxapine, amoxapine and their 7- and 8-hydroxy metabolites in plasma by high-performance liquid chromatography”. Journal of Chromatography 564 (1): 213–21. DOI:10.1016/0378-4347(91)80083-O. PMID 1860915. 
  8. Schmutz, J.; Kunzle, F.; Hunziker, F.; Gauch, R.; Helv. Chim. Acta 1967, 50, 245.

Vanjske veze

[uredi | uredi kod]
pFad - Phonifier reborn

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy